Mersana Therapeutics Inc (NASDAQ:MRSN) currently has a daily average trading volume of 5.12M but it saw 3312186 shares traded in last market. With a market cap of 62.12M USD, the company’s current market price of $0.50 came falling about -8.56 while comparing to the previous closing price of $0.55. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.28 and as low as $0.49.
Taking a look at 20-day trading activity of Mersana Therapeutics Inc (MRSN) gives us an average price of $0.6054, while its current price level is -91.99% below from 52-week high level whereas it is 2.36% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.9411 while that of 200 days or SMA-200 reads an average of $1.7559. A closer look into the stock’s movement over the week reveals that its volatility is standing at 11.25% during that period while stretching the period over a month that increases to 12.13%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 33.32 which implies that the stock is in neutral territory.
JP Morgan issued its recommendations for the stock as it upgraded the price target for the stock is $5.
Over the week, MRSN’s stock price is moving -4.75% down while it is -22.33% when we observe its performance for the past one month. Year-to-date it is -64.83% down and over the past year, the stock is showing a downside performance of -87.61%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.17 while estimate for next year EPS is -0.61. In next quarter, company is expected to be making quarterly sales of $5.2M as analysts are expecting the sales for current fiscal year at $31.03M and seeing the company making $22.76M in sales next year. Moreover, analysts are in estimates of $7.71M for current-quarter revenue.
Currently, Mersana Therapeutics Inc’s total number of outstanding shares is 122.87M with 1.50% of that held by the insiders while 92.15% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -430.25% and return on equity (ROE) at -280.29%. Stock’s beta reads 1.64. Stock has a price to book (P/B) ratio of 58.89 while price to sale or P/S ratio amounts to 1.78. Its return on asset (ROA) is -34.51% on average.
